GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Missouri judge approves Bayer's $7.25 billion Roundup settlement - Finance news and analysis from Global Banking & Finance Review
Finance

Missouri judge approves Bayer's $7.25 billion Roundup settlement

Published by Global Banking & Finance Review

Posted on November 20, 2026

3 min read

· Last updated: November 20, 2026

Add as preferred source on Google

Missouri Judge Approves $7.25 Billion Roundup Settlement for Bayer

Overview of the Roundup Settlement and Its Implications

Background of the Litigation

Nov 20 (Reuters) - A Missouri judge on Friday approved Bayer's $7.25 billion settlement of lawsuits alleging that its weedkiller Roundup causes cancer, a decision that could ultimately resolve litigation that has weighed on the company for a decade.

Bayer is facing approximately 65,000 claims in US state and federal courts from plaintiffs who say they developed cancer after using Roundup at home or on the job. The settlement, announced in February, aims to ​resolve nearly all current and future Roundup claims in the US.

History of Bayer's Legal Challenges

The litigation has weighed on Bayer since its 2018 acquisition of Monsanto, costing the company billions of dollars and driving down its share price. The company previously spent about $10 billion in 2020 to resolve most of the then-existing Roundup lawsuits, but Bayer was unable to gain court approval of a parallel $1.25 billion settlement that would have resolved future Roundup claims. 

Bayer's Position on Roundup Safety

Bayer has denied the claims and said that decades of studies ​have shown Roundup's key ingredient, glyphosate, is safe and does not cause cancer.

Details of the Settlement

The proposed settlement offers payouts ranging from $10,000 to $165,000 to people who were exposed to ‌Roundup and ⁠developed non-Hodgkin lymphoma, a form of cancer. The exact award will depend on factors such as the severity of the person's cancer, how old they were when they were diagnosed, and whether they were exposed to Roundup at home or at work.

Supreme Court Ruling and Its Impact

When Bayer announced the settlement, it was still awaiting a US Supreme Court ruling on whether it could be sued over its government-approved warning label for Roundup. Bayer ultimately won that case, undercutting a central claim in many of the lawsuits. 

Reactions to the Settlement

Plaintiffs' attorneys who support the settlement have said the deal ensures that people with cancer will get paid, at a time when litigation is more uncertain than ever after the Supreme Court ruling ​in Bayer's favor. Opponents argued that the deal ​does not offer enough money, and they said the settlement is designed to trap current and future claimants who would prefer to pursue their lawsuits in court.

Ongoing Litigation and Exclusions

The deal excludes lawsuits that have been consolidated in an ongoing federal court proceeding. Bayer says about 200 of those cases are still being litigated, and it has argued that the Supreme Court's ruling gives it strong defenses to those cases.

(Reporting by Dietrich Knauth and Jonathan Stempel, Editing by Alexia Garamfalvi and Matthew Lewis)

Key Takeaways

  • Judge Timothy Boyer in St. Louis gave final approval on November 20, 2026, to a $7.25 billion class‑action settlement covering current and future U.S. Roundup claims (kfgo.com).
  • Payouts range from approximately $10,000 (for older or residential claimants) to $165,000 (for younger, occupational claimants with aggressive non‑Hodgkin lymphoma) (dovel.com).
  • The settlement funding spans up to 21 years via declining capped annual payments and resolves most litigation following uncertainty heightened by a favorable June Supreme Court ruling for Bayer (bayer.com).

References

Frequently Asked Questions

What is the amount of Bayer's Roundup cancer lawsuit settlement?
Bayer's Roundup settlement approved by a Missouri judge is valued at $7.25 billion.
Who is eligible for payouts under the Roundup settlement?
People exposed to Roundup who developed non-Hodgkin lymphoma are eligible for payouts, with awards ranging from $10,000 to $165,000.
How many lawsuits does Bayer still face over Roundup in the US?
Bayer still faces about 65,000 claims in US state and federal courts, with around 200 consolidated federal cases continuing.
Why has the Roundup litigation been significant for Bayer's finances?
The litigation has cost Bayer billions of dollars and impacted its share price since acquiring Monsanto in 2018.
Did the Supreme Court rule in Bayer's favor on Roundup lawsuits?
Yes, the Supreme Court ruled in Bayer's favor regarding lawsuits over Roundup's government-approved warning label.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category